Compare Enzyme (MLN) vs DefiTuna (TUNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs DefiTuna — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while DefiTuna trades at Rp74.46 (market cap --, Rp85,25jt 24h volume). The key difference: Enzyme's circulating supply is 3,3M MLN versus -- for DefiTuna, and Enzyme is more actively traded (Rp104,56M versus Rp85,25jt). Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and DefiTuna for 8 Days on average.
| MLN | TUNA | |
|---|---|---|
Market Cap | Rp134,13M | -- |
Volume (24h) | Rp104,56M | Rp85,25jt |
Circulating Supply | 3,3M MLN | -- |
Typical Hold Time | 28 Days | 8 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
DefiTuna faces significant data limitations with current price and market metrics unavailable, though it maintains a fixed max supply of 1M tokens. The token shows a relatively short average hold time of 8 days, suggesting active trading rather than long-term holding. No recent protocol updates or ecosystem developments are documented, indicating limited current network activity.
Outlook remains speculative due to insufficient market data and development activity. Key opportunity lies in the fixed supply model if adoption increases, while major risks include extreme volatility, low liquidity, and regulatory uncertainty typical of emerging crypto assets. Investors should exercise caution given the information gaps.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About DefiTuna
DefiTuna is a DeFi infrastructure layer for leveraged liquidity on Solana. Now powered by Fusion AMM—an on-chain model combining concentrated liquidity and transparent limit orders—it unifies lending, leverage, and AMMs to enable capital-efficient trading and liquidity strategies.
Read more on TUNA →
